SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 78 puts the business in the 98th percentile for manufacturers of glass and glass products.
SGD Pharma has launched a new range of innovative Type I tubular vials for injectable drugs with an external low coefficient of friction (COF) coating developed by Corning, to help manufacturers optimize their fill and finish operations. Disruptions on pharmaceutical filling lines may be caused by tip-overs, jams and glass breakages, all due to frictional resistance from glass-to-glass and glass-to-metal contact. Damage and disruption to the flow of vials may result in recalls and increased manufacturing costs.
We are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin Lamotte (SQLM) plant, which safeguards the integrity of sensitive, aggressive and viscous drug products.
What is siliconization?
SGD Pharma marked the start of the New Year by celebrating the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2 with a lighting ceremony performed by our appointed Godmother, Vanessa Rade, in accordance with glassmaking tradition.
